GlassScriptPhysician profile
Nathan J Lashley
NPI 1598995649
$6,322.53
in general payments reported to CMS, 2019-2025
41 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,707 · 2020: $678 · 2021: $511 · 2022: $733 · 2023: $558 · 2024: $650 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,693.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,264.08 | 2019-2025 | |
| Paragon 28, INC. | $1,212.34 | 2019 | |
| Organogenesis INC. | $475.20 | 2020-2025 | Puraply, Cygnus Dual |
| Smith+Nephew, INC. | $338.99 | 2019-2025 | Collagenase Santyl, Na |
| Horizon Therapeutics Plc | $306.72 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $303.84 | 2020-2025 | Nuzyra |
| Zyla Life Sciences, INC. | $264.04 | 2019-2020 | |
| Depuy Synthes Sales INC. | $221.60 | 2021-2025 | Motoband, Fibergraft Bg Morsels |
| Merck Sharp & Dohme LLC | $208.28 | 2019 | |
| Abbvie INC. | $187.69 | 2021-2025 | |
| Integra Lifesciences Corporation | $164.78 | 2019-2020 | |
| Amgen INC. | $122.93 | 2024 | Krystexxa |
| Pfizer INC. | $103.35 | 2020-2025 | |
| Polynovo North America LLC | $93.05 | 2023-2025 | Novosorb Btm |
| Abbott Laboratories | $82.20 | 2019-2024 | Proclaim |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $81.57 | 2024 | |
| Next Science LLC | $78.63 | 2022-2023 | Surgx, Xperience, Blastx |
| Bioventus LLC | $77.22 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Nabriva Therapeutics, Plc | $74.51 | 2020-2022 | |
| Kerecis Limited | $68.13 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Stryker Corporation | $67.48 | 2024-2025 | Iconix, Citrefix |
| Medtronic, INC. | $60.25 | 2022-2023 | Intellis Adaptivestim |
| Treace Medical Concepts, INC. | $40.74 | 2024-2025 | |
| Osiris Therapeutics INC. | $37.23 | 2019 | |
| Solventum Corporation | $35.52 | 2025 | 3m Cavilon, Activ.A.C., 3m Coban |
| Reprise Biomedical, INC. | $31.76 | 2024-2025 | Miro3d |
| Zimmer Biomet Holdings, INC. | $29.51 | 2020 | |
| Averitas Pharma INC. | $28.62 | 2025 | Qutenza |
| Convatec INC. | $26.70 | 2022 | |
| Grt US Holding, INC. | $25.89 | 2021-2022 | |
| Inari Medical, INC. | $24.89 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| P Bar Medical LLC | $24.07 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $22.64 | 2024 | |
| Arthrosurface Incorporated | $21.07 | 2019 | |
| Nalu Medical, INC. | $20.23 | 2023 | Nalu Neurostimulation System |
| Heron Therapeutics, INC. | $19.81 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.79 | 2023 | Jublia |
| Kowa Pharmaceuticals America, INC. | $19.11 | 2023 | Seglentis |
| Wright Medical Technology, INC. | $17.26 | 2020 | |
| Melinta Therapeutics, LLC | $16.56 | 2019 | |
| Assertio Therapeutics, INC. | $4.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Lashley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.